Surmodics Receives FDA Approval for the SurVeil™ Drug-Coated Balloon

Author's Avatar
Jun 20, 2023

Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the receipt of U.S. Food and Drug Administration (FDA) approval for the SurVeil™ drug-coated balloon (DCB).